Predictor factors of prism effectiveness in young adults with convergence insufficiency

Hassan Hashemi1, Ebrahim Jafarzadehpur2, Payam Nabovati2

  • 1Noor Research Center for Ophthalmic Epidemiology, Noor Eye Hospital, Tehran, Iran.

Insights

Prism effectiveness in convergence insufficiency is predicted by prism adaptation rate. Lower adaptation rates correlate with increased prism effectiveness, guiding patient selection and prism prescription.

Area of Science:

  • Ophthalmology
  • Optometry
  • Vision Science

Background:

  • Convergence insufficiency (CI) is a common condition affecting binocular vision.
  • Prism prescription is a potential treatment for CI, but its effectiveness varies.
  • Understanding factors influencing prism effectiveness is crucial for optimizing treatment outcomes.

Purpose of the Study:

  • To investigate the relationship between demographic and clinical characteristics and prism effectiveness in young adults with CI.
  • To identify predictors of prism effectiveness for guiding patient selection and prism prescription.

Main Methods:

  • A randomized clinical trial involving 64 young adults diagnosed with CI.
  • Participants were assigned to either a treatment group (base-in prism) or a placebo group.
  • Outcome assessments were conducted after three months of intervention.

Main Results:

  • Univariate analysis indicated that a remote near point of convergence, higher baseline symptoms, and higher prescribed prism power were associated with increased prism effectiveness.
  • Near positive fusional vergence, vergence facility, and prism adaptation rate showed an inverse relationship with prism effectiveness.
  • Multiple regression analysis identified prism adaptation rate as the sole independent predictor of prism effectiveness (effectiveness increased by 0.60 for each 1% reduction in adaptation rate).

Conclusions:

  • Prism adaptation rate is the only independent predictive factor for prism effectiveness in young adults with convergence insufficiency.
  • Careful assessment of prism adaptation should be considered prior to prescribing prisms for CI.